Chemotherapy for lymphatic filariasis: progress but not perfection
Melrose, Wayne D. (2003) Chemotherapy for lymphatic filariasis: progress but not perfection. Expert Review of Anti-infective Therapy, 1 (4). pp. 571-578.
|PDF (Published Version) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://dx.doi.org/10.1586/14787188.8.131.52...
Currently, only three drugs are used to control and treat the mosquito-borne parasitic disease lymphatic filariasis: diethylcarbamazine, ivermectin (Mectizan®) and albendazole (Zentel®). All interrupt transmission by eliminating microfilaria, the parasite stage that is responsible for transmission between hosts, but do not reliably kill the adult worms that are responsible for much of the pathology seen in the disease. There is an urgent need to develop drugs that will reliably kill adult worms and several compounds are under-going in vitro and animal testing. An alternative strategy – that of targeting symbiont bacteria within the parasite – has also shown promising results.
|Item Type:||Article (Refereed Research - C1)|
|Keywords:||chemotherapy; lymphatic filariasis; albendazole; diethylcarbamazine; ivermectin; microfilaria|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1108 Medical Microbiology > 110803 Medical Parasitology @ 100%|
|Deposited On:||17 May 2010 11:07|
|Last Modified:||12 Feb 2011 02:57|
Last 12 Months: 0
|Citation Counts with External Providers:|
Repository Staff Only: item control page